Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2011; 6(8): e23633.
Published online 2011 Aug 30. doi:  10.1371/journal.pone.0023633
PMCID: PMC3166063

Reduced Neutrophil Apoptosis in Diabetic Mice during Staphylococcal Infection Leads to Prolonged Tnfα Production and Reduced Neutrophil Clearance

Vance G. Fowler, Editor


Diabetes is a frequent underlying medical condition among individuals with Staphylococcus aureus infections, and diabetic patients often suffer from chronic inflammation and prolonged infections. Neutrophils are the most abundant inflammatory cells during the early stages of bacterial diseases, and previous studies have reported deficiencies in neutrophil function in diabetic hosts. We challenged age-matched hyperglycemic and normoglycemic NOD mice intraperitoneally with S. aureus and evaluated the fate of neutrophils recruited to the peritoneal cavity. Neutrophils were more abundant in the peritoneal fluids of infected diabetic mice by 48 h after bacterial inoculation, and they showed prolonged viability ex vivo compared to neutrophils from infected nondiabetic mice. These differences correlated with reduced apoptosis of neutrophils from diabetic mice and were dependent upon the presence of S. aureus and a functional neutrophil respiratory burst. Decreased apoptosis correlated with impaired clearance of neutrophils by macrophages both in vitro and in vivo and prolonged production of proinflammatory tumor necrosis factor alpha by neutrophils from diabetic mice. Our results suggest that defects in neutrophil apoptosis may contribute to the chronic inflammation and the inability to clear staphylococcal infections observed in diabetic patients.


Diabetes mellitus is a group of metabolic disorders characterized by hyperglycemia. Patients with type 1 diabetes fail to produce insulin, and patients with type 2 diabetes develop resistance to insulin. The incidence of diabetes mellitus continues to rise, especially in developed countries [1], [2]. While the prevalence of diabetes currently lies between 6% and 10%, it is estimated that individuals born in the United States in the year 2000 have a risk of 1 in 3 to develop diabetes during their lifetime [3]. Although type 1 and type 2 diabetes differ in their respective etiologies, both forms share complications such as vasculopathy, nephropathy, retinopathy and neuropathy. Additionally, diabetes is associated with deficiencies in wound healing, chronic inflammation and enhanced susceptibility to infection. Diabetic foot infections are a major complication of diabetes mellitus [4], and chronic leg ulcers are a frequent cause for hospitalizations and amputations among diabetic patients. Staphylococcus aureus is a bacterial pathogen frequently implicated in these chronic infections. S. aureus nasal carriage, a known risk factor for staphylococcal disease, is higher among diabetic patients than healthy individuals [5], [6]. Invasive staphylococcal infections (such as endocarditis or bacteremia) are more prevalent in diabetic than in nondiabetic patients and are associated with a poor outcome in patients with diabetes [7], [8]. In studies of diabetic rodents, chronic wounds were characterized by tissue persistence of inflammatory cells, such as neutrophils [9], [10], and prolonged expression of proinflammatory cytokines [11]. Whereas some authors report impaired bactericidal function and decreased phagocytic activity by neutrophils from diabetic patients [12], [13], others have failed to demonstrate significant differences in neutrophil function in diabetic versus control patients [14]. Some of these conflicting findings may be explained by heterogeneous patient populations. Animal models of diabetes offer the advantage of examining the function and fate of neutrophils in defined models of infections [15][17].

Neutrophils are short-lived but abundant leukocytes. They are rapidly recruited to the site of a bacterial infection and are generally considered to be part of the “first line of defense” of the host innate immune system. Because of their sheer numbers, as well as their toxic contents and elaboration of proinflammatory cytokines, neutrophil clearance is key to the resolution of the inflammatory response and hence tightly regulated [18], [19]. Neutrophil apoptosis (either spontaneous or pathogen induced) is crucial for neutrophil uptake and subsequent elimination by macrophages at the site of infection, leading to resolution of the inflammatory process [20]. To address whether dysregulated neutrophil apoptosis during S. aureus infection might contribute to the severity and chronicity of bacterial infections observed in diabetic patients, we utilized a mouse model of invasive S. aureus infection in a diabetic host.


Ethics Statement

Animal experiments were performed in accordance with the guidelines of the Harvard Medical School Standing Committee on Animals (Animal Welfare Assurance Number A3431-01) under approved protocol 03565. The Harvard Medical School animal management program is accredited by the American Association for Accreditation of Laboratory Animal Care and meets National Institutes of Health standards as set forth in “Guide for the Care and Use of Laboratory Animals” (DHSS Publication No. (NIH) 85-23 Revised 1985). The institution also accepts as mandatory the Public Health Service “Policy on Humane Care and Use of Laboratory Animals by Awardee Institutions” and NIH “Principles for the Utilization and Care of Vertebrate Animals Used in Testing, Research and Training.”

Mouse model of S. aureus infection

NOD mice were derived by Makino et al. [15] by selective inbreeding of a single female glucosuric mouse from a substrain of ICR mice. Female NOD mice spontaneously develop type 1 diabetes between 15 and 30 weeks of age [16], and by 20 weeks of age, 70–80% of females become diabetic. We obtained NOD mice from The Jackson Laboratories (Bar Harbor, ME), and some of the animals were bred in our facility. The mice were housed in a modified barrier facility under viral antibody-free conditions and were fed an autoclaved diet. Blood glucose levels were tested with glucostrips (Bayer, Elkhart, IN), and blood ketone levels were tested with PrecisionXtra β-Ketone Test strips (Abbott Laboratories, Alameda, CA). Nondiabetic mice were normoglycemic with blood glucose levels below 125 mg/dl (7 mmol/l). Diabetic mice had negative or low blood acetone levels, normal body weight, and blood glycemia levels ≥450 mg/dl (25 mmol/l) at the time of bacterial challenge.

Female diabetic (age 13–25 weeks) mice and control age-matched nondiabetic female littermates were challenged intraperitoneally (IP) with 108 CFU S. aureus strain PS80 (a capsular serotype 8 isolate) cultured overnight on Columbia salt agar, and the animals were euthanized thereafter at the indicated time points. The peritoneal cavity was lavaged with 5 ml PBS, the total inflammatory cells were harvested, and a differential cell count determined. The S. aureus CFU/ml peritoneal fluid was determined by quantitative plate counts.

Neutrophil isolation and ex vivo incubation

Neutrophils were isolated from peritoneal exudates of S. aureus-infected diabetic and nondiabetic mice by density gradient centrifugation. Peritoneal lavage fluids were overlaid on a 62% Percoll gradient and centrifuged for 25 min at 1200 g at room temperature. Contaminating erythrocytes were removed by hypotonic lysis. After two additional washes in PBS, viable neutrophils were enumerated by trypan blue exclusion, suspended in Minimum Essential Medium (MEM) supplemented with 10% fetal calf serum (FCS) and 100 ug/ml gentamicin (Gm) to prevent extracellular bacterial growth and incubated ex vivo. Neutrophil viability and apoptosis were measured at time zero and after 6 or 12 h of incubation at 37°C.

Alternatively, neutrophils were recruited to the mouse peritoneal cavity by IP injection of 1 ml of a 9% casein solution as a sterile inflammatory stimulus 18 h and again 3 h before euthanasia. Where indicated, neutrophils were stimulated ex vivo with S. aureus (pre-opsonized for 20 min with normal mouse serum stored at −80°C to preserve complement activity) at a bacterium to cell ratio of 1∶1 or 5∶1. After an incubation time of 1 h at 37°C, the neutrophils were washed, resuspended in MEM/FCS with 100 µg/ml Gm and further incubated at 37°C for 6 or 18 h.

Apoptosis assays

Neutrophil apoptosis was assessed by three methods. Phosphatidylserine exposure on the outer cell membrane was measured using an annexin binding assay (BD Biosciences, San Jose, CA) according to the manufacturer's instructions. In brief, 1.5×105 neutrophils were washed, resuspended in 100 µl PBS and labeled with PE-labeled Ly6G antibody (eBioscience, San Diego, CA) for 15 min on ice. After washing away unbound antibodies, cells were resuspended in 100 µl binding buffer, 5 µl FITC labeled annexin V and 5 µl 7-amino-actinomycin D (AAD) to exclude dead cells. After incubation for 20 min in the dark, the percentage of annexin(+), AAD(−), Ly6G(+) cells was analyzed by flow cytometry (BD FACSCalibur®). Nuclear condensation was measured by suspending neutrophils in PBS and air drying them on a microscope slide. Cells were stained for 10 min with 10 µg/ml Hoechst 33342 (Invitrogen, Carlsbad, CA), mounted in PBS/glycerol, and at least 200 cells were counted using fluorescence microscopy. Cells with condensed and fragmented nuclei were scored as apoptotic. DNA strand breaks were assessed with a TUNEL staining procedure (Roche Applied Science, Indianapolis, IN). In brief, 2×105 neutrophils were fixed in cold paraformaldehyde, washed in PBS and permeabilized overnight in cold 70% ethanol in PBS. The neutrophils were washed in TUNEL dilution buffer, labeled with TUNEL reaction mix according to the manufacturer's protocol, washed and incubated with PE-labeled Ly6G antibodies. The percentage of TUNEL(+), Ly6G(+) cells was assessed by flow cytometry.

Intracellular tumor necrosis factor alpha (TNFα) staining

Neutrophils were isolated as described above from the peritoneal lavage fluids of diabetic or nondiabetic mice 18 h after IP challenge with S. aureus. The cells were washed, suspended in MEM/FCS + 100 µg/ml Gm, and incubated for 3 h with Brefeldin A (1 ng/ml; GolgiPlug®, BD Biosciences). Alternatively, the isolated neutrophils were incubated ex vivo for 7 h at 37°C before a 3-h Brefeldin A treatment (leading to total incubation time of 10 h). TNFα production was measured using an intracellular cytokine staining procedure. The neutrophils were washed, fixed in 4% paraformaldehyde for 20 min, pelleted and resuspended in PBS/FCS for overnight storage at 4°C. After an additional wash, the neutrophils were suspended in Wash/Perm buffer (BD Biosciences) and labeled with FITC-labeled Ly6G and PE-labeled mouse TNFα antibodies (both eBioscience). After two washes, the neutrophils were suspended in PBS, and the percentage of Ly6G(+) TNFα (+) cells was determined by flow cytometry.

Phagocytosis of neutrophils by macrophages – in vitro

Neutrophils isolated from peritoneal exudates of S. aureus-infected mice were labeled with CellTracker® Green (Invitrogen) for 15 min, washed, resuspended in MEM containing 100 µg/ml Gm, and incubated for 8 h at 37°C to induce apoptosis. Macrophages from the mononuclear fraction of the same exudates were adhered to glass cover slips in tissue culture plates at a concentration of 3×105 cells/well, and nonadherent cells were washed away after 90 min. After a total incubation time of 8 h, adherent macrophages were overlaid with 3×106 labeled neutrophils, incubated for 2 h and then washed thoroughly with PBS. The remaining adherent cells were stained with CellMask® Orange (Invitrogen), washed and fixed in paraformaldehyde. Slides were mounted in antifade solution (50% glycerol in PBS with 2% n-propyl-gallate) and examined by fluorescence microscopy. The percentage of macrophages with internalized neutrophils was calculated from a minimum of 200 cells counted.

Phagocytosis of neutrophils by macrophages – in vivo

Neutrophils purified from peritoneal exudates of S. aureus-infected diabetic or nondiabetic mice were labeled for 15 min with CellTracker® Green, washed, and suspended in PBS. The labeled neutrophils (2×106 neutrophils per mouse) were injected IP into diabetic or nondiabetic mice infected with 108 CFU S. aureus for 20 h. Peritoneal exudates were recovered from the recipient animals 3 h later, and the mononuclear cells were purified, washed, and labeled with PE-labeled F4/80 antibodies (eBioscience). The cells were fixed in paraformaldehyde, and the percentage of macrophage-associated (F4/80+) CellTracker Green labeled neutrophils was determined by flow cytometry.

Statistical analysis

Results were expressed as means ± standard error of the mean (SEM), and Shapiro-Wilk tests were used to verify the assumption of a normally distributed data set. The data shown in Figs. 1 and and22 were analyzed by the unpaired Student t test. However, in all subsequent experiments each mouse was compared individually to an age-matched normoglycemic littermate since NOD mice developed diabetes between 13 and 25 weeks of age, . As a result, data sets comparing age-matched diabetic and nondiabetic mice were analyzed with a two-tailed paired Student t test. A P-value of <0.05 was considered to be statistically significant.

Figure 1
Diabetic mice show enhanced susceptibility to systemic S. aureus infection.
Figure 2
Cellular kinetics of peritoneal fluids recovered from S. aureus infected mice.


Systemic model of S. aureus infection in nondiabetic and diabetic mice

Our previous studies revealed that a localized S. aureus PS80 infection of the hindpaw tissues was exacerbated in diabetic NOD mice compared to that of nondiabetic mice, and the diabetic animals were unable to clear the infection over a 10-day period. We observed delayed neutrophil recruitment to the site of infection in the diabetic mice, and this finding was consistent with chemokine levels in the infected hindpaw tissues of the diabetic mice that were significantly lower than those of age-matched nondiabetic littermates [17]. In this study age-matched nondiabetic or diabetic mice were challenged IP with 108 CFU S. aureus PS80. All the mice developed a nonlethal acute peritonitis and were bacteremic. The diabetic mice showed impaired clearance of the systemic infection compared to the nondiabetic mice, who cleared the peritoneal infection within 5 days (Fig. 1).

To determine whether the delayed clearance of S. aureus from the peritoneal cavity and blood of diabetic mice was due to an impaired inflammatory response, we measured the numbers of total leukocytes recruited to the peritoneal cavity at various time points following S. aureus challenge. The total cell number in the peritoneal lavage fluid was increased from ∼106 to 107 cells/ml peritoneal fluid in both diabetic and nondiabetic mice after S. aureus inoculation, and the kinetics of cell migration were similar in both groups (Fig. 2A). Diabetic animals showed an increased bacterial burden at the early time points (<24 h post bacterial challenge), but no delay in neutrophil recruitment to the peritoneal cavity was observed (Fig. 2B). Diabetic mice showed significantly higher neutrophil counts in the peritoneal cavity 48 h and 120 h after challenge with S. aureus (Fig. 2). Overall, the percentage of each cell type - neutrophils, macrophages, and lymphocytes - recruited to the peritoneal cavity was similar in diabetic and nondiabetic animals.

Enhanced viability of diabetic neutrophils

In an attempt to explain the failure of diabetic mice to clear the staphylococcal infection despite an apparently adequate inflammatory response, we assessed the bactericidal activity of neutrophils recruited to the peritoneal cavity following the administration of a sterile inflammatory stimulus (casein). No difference in killing capacity between the two mouse groups was apparent, since neutrophils from diabetic and nondiabetic mice killed 65–70% of opsonized S. aureus within 1 h ex vivo.

Because the neutrophils recruited to the peritoneal cavity of diabetic mice appeared functionally intact, we hypothesized that they might show impaired clearance from the infection site, and that this finding might correlate with the persistent inflammation observed in diabetic hosts. To test neutrophil viability without interference by variable bacterial numbers recovered in vivo, we isolated neutrophils from mouse peritoneal exudates 18 h after challenge with S. aureus, i.e. at a time point where bacterial loads in the peritoneal cavity were similar in diabetic and nondiabetic animals and similar numbers of neutrophils were recovered from the peritoneal lavage fluids. The neutrophils were incubated for either 6 or 12 h ex vivo at 37°C, and cell viability was assessed microscopically by trypan blue exclusion. Pair-wise comparisons showed that 72% of neutrophils from diabetic mice remained viable after 6 h compared with 63% of neutrophils from nondiabetic mice (Fig. 3; P = 0.039). This modest yet reproducible difference in viability was abrogated by 12 h, when only ∼30% of neutrophils from either group of mice remained viable.

Figure 3
Viability of neutrophils isolated from the peritoneal cavities of diabetic and nondiabetic mice infected for 18 h with S. aureus PS80.

S. aureus induced apoptosis is reduced in neutrophils from diabetic mice

Since neutrophil apoptosis is the main mode of cell death in mature neutrophils, we set out to test whether delayed apoptosis might contribute to the observed increase in the viability of neutrophils from diabetic mice. Direct examination of peritoneal exudate fluids revealed few apoptotic neutrophils, which may be due to efficient in vivo clearance by macrophages. Neutrophils, isolated 18 h after challenge with S. aureus, were subsequently incubated ex vivo for up to 18 h. Since some variability was observed among the experimental animals, we tested age-matched female diabetic and nondiabetic mice in pair-wise comparisons. Phosphatidylserine exposure (annexin V binding), DNA strand breaks (TUNEL staining) and nuclear condensation were measured as different hallmarks of cellular apoptosis. Neutrophils recovered from the peritoneal cavities of S. aureus infected diabetic mice (without additional incubation) showed similar annexin binding to neutrophils from control mice (15.9±3.4% versus 18.6±5.4%). However, upon further incubation ex vivo, neutrophils from diabetic mice bound significantly less annexin than neutrophils from nondiabetic mice at 6 h (P = 0.009) and 12 h (P = 0.0098) (Figs. 4A and 4D). Similarly, neutrophils from diabetic mice showed reduced TUNEL staining 6 h after isolation (P = 0.049; Figs. 4B and 4D) compared to neutrophils from diabetic mice. Nuclear condensation was likewise reduced at both 6 h (P = 0.032) and 12 h (P = 0.013) after isolation when neutrophils from diabetic and nondiabetic mice were compared (Figs. 4C and 4D). Together these results indicate that neutrophils from diabetic mice show a significantly reduced rate of apoptosis in response to S. aureus infection compared to neutrophils from age-matched nondiabetic mice (Fig. 4D).

Figure 4
Neutrophil apoptosis—in vivo infection.

To address whether the differences in neutrophil apoptosis were pathogen dependant or due to aberrant constitutive apoptosis, we evaluated the fate of neutrophils recruited to the peritoneal cavity following injection of casein. Neutrophils were isolated from murine peritoneal exudates and incubated ex vivo with or without pre-opsonized S. aureus. Spontaneous neutrophil apoptosis (as measured by percent annexin-positive cells) was similar for diabetic and nondiabetic mice at both 6 h (21.8±4.3% versus 22.9±3.8%) and 18 h (55.0±6.5% versus 61.2±5.0%) after isolation. When opsonized S. aureus cells were added to the murine neutrophil suspension at a multiplicity of infection (MOI) of 1, apoptosis of neutrophils from diabetic or nondiabetic mice was similar at 6 h (32.3±2.7% versus 37.0±2.7%). However, significantly (P<0.01) fewer apoptotic cells were found among neutrophils from diabetic animals than nondiabetic mice after 18 h (Fig. 5). Increasing the MOI to 5 led to noticeable differences as early as 6 h after exposure to S. aureus with significantly (P = 0.012) fewer annexin-positive cells in the diabetic compared to the nondiabetic sample. These results indicate that the decrease in apoptosis characteristic of neutrophils from diabetic mice was specific for neutrophils exposed to S. aureus.

Figure 5
Neutrophil apoptosis—ex vivo infection.

We previously demonstrated that peripheral blood neutrophils from diabetic mice showed a diminished respiratory burst upon ingestion of S. aureus compared to neutrophils from nondiabetic mice [17]. A functional NADPH-oxidase is essential for the induction of apoptosis (as measured by phosphatidylserine exposure) upon ingestion of S. aureus, and a lack of NADPH-oxidase activity leads to elevated neutrophil numbers in the peritoneal cavities of mice challenged with heat-killed staphylococci [21]. To determine whether the reduced apoptosis observed in diabetic mice was due to a lower oxidative burst in neutrophils from diabetic animals, we incubated casein-elicited neutrophils from the peritoneal cavities of diabetic or nondiabetic mice with opsonized S. aureus in the presence or absence of diphenyleneiodonium (DPI), an inhibitor of the NADPH-dependant oxidase. As shown in Fig. 5, the differences in neutrophil apoptosis (measured by annexin binding) between diabetic and nondiabetic mice were reduced in the absence of a functional NADPH oxidase enzyme, suggesting that differences in the oxidative burst contribute to the reduced apoptosis of neutrophils from diabetic animals infected with S. aureus.

Neutrophils from S. aureus infected diabetic mice fail to down-regulate cytokine production

Kobayashi et al. demonstrated that the expression of proinflammatory cytokines by human neutrophils was down-regulated during phagocytosis-induced apoptosis [22]. Failure to undergo apoptosis may thus lead to prolonged production of these inflammatory cytokines by neutrophils. To determine whether neutrophils from diabetic mice might show prolonged cytokine production due to delayed apoptosis, we measured intracellular TNFα (a representative proinflammatory cytokine) in neutrophils isolated from the peritoneal cavities of diabetic or nondiabetic mice 18 h after challenge with S. aureus. After ex vivo neutrophil aging, neutrophil expression of TNFα was detected using an intracellular cytokine staining procedure. Three hours after isolation, equivalent numbers of neutrophils from diabetic and nondiabetic mice stained positive for TNFα (Fig. 6). Whereas 55.8±7.7% of neutrophils from control animals were TNFα-positive after 3 h, only 23.8±3.2% stained positive after 10 h (P = .002). In contrast, no significant reduction in TNFα positive neutrophils from diabetic mice occurred over time (50.5±8.3% at 3 h versus 43.2±5.7% at 10 h, P = .59). Consequently, significantly (P = .036) more neutrophils from diabetic mice stained positive for TNFα than neutrophils from nondiabetic mice after 10 h (Fig. 6).

Figure 6
TNFα production by neutrophils isolated from the peritoneal cavities of mice 18 h after IP challenge with 108 CFU S. aureus PS80.

Clearance of S. aureus stimulated neutrophils is reduced in diabetic mice

Programmed cell death in neutrophils results in recognition, uptake and clearance by macrophages [20]. To determine whether neutrophil uptake and removal by macrophages differed between diabetic and nondiabetic animals, we designed in vitro and in vivo experiments. We isolated and labeled neutrophils recovered from the peritoneal cavities of S. aureus-infected diabetic and nondiabetic mice. For in vitro experiments, the neutrophils were aged for 8 h and then incubated for 2 h with adherent autologous macrophages. The macrophage cultures were washed, and cells with ingested fluorescent neutrophils were counted by microscopy. Samples from diabetic animals had significantly fewer macrophages with ingested neutrophils than samples from nondiabetic controls (8.4±0.3% versus 13.4±1.4%, P = 0.028; Fig. 7).

Figure 7
In vitro phagocytosis of apoptotic neutrophils by murine macrophages.

Phagocytosis of apoptotic neutrophils by macrophages not only depends on the recognition of apoptotic neutrophils by macrophage receptors but also on several serum derived factors [23]. To validate our in vitro findings, we performed in vivo experiments whereby we injected labeled donor neutrophils (isolated from diabetic or nondiabetic mice 18 h after IP challenge with S. aureus) into corresponding (i.e. diabetic or nondiabetic) recipient animals 24 h after IP challenge with S. aureus. Peritoneal cavities were lavaged 3 h later, and the percentage of fluorescent neutrophils that colocalized with macrophages was measured by flow cytometry. Consistent with our in vitro data, diabetic animals showed fewer labeled neutrophils (20.8±2.0%) associated with macrophages than the nondiabetic control animals (30.5±3.6%; P = 0.026, Fig. 8).

Figure 8
In vivo phagocytosis of apoptotic neutrophils by murine macrophages.


The rising prevalence of both type 1 and type 2 diabetes worldwide [1], [2], [24] has led to an increasing incidence of diabetes-associated complications. While intensive research has been carried out on the epidemiology, pathogenesis and major complications of diabetes, the pathophysiology of infectious and inflammatory complications has received less attention. Ketoacidosis in patients with type 1 diabetes is frequently precipitated by infections [25], and diabetic patients in general are more susceptible to a variety of infections [26], [27], especially those caused by S. aureus. Diabetic patients have a higher rate of nasal colonization with S. aureus than healthy controls [28], [29], and S. aureus is frequently isolated from diabetic foot infections, which are a major cause for hospitalization of diabetic patients [30]. Diabetes is a risk factor for invasive S. aureus disease [8], including pneumonia [31]. Moreover, diabetes mellitus is the second most common underlying comorbidity in S. aureus bacteremia cohorts, and diabetes is associated with a poorer outcome both in bacteremia and endocarditis [32][34]. With regard to leukocyte function in diabetes mellitus, the available data are conflicting. Whereas some authors report differences in neutrophil metabolism [35], cytokine production [36], respiratory burst [17] or bacterial killing [37], [38], other studies failed to detect significant reductions in neutrophil function in diabetic hosts [39]. Delayed healing of chronic wounds in diabetic hosts has been linked to persistent inflammation reflected by high neutrophil and macrophage numbers and elevated levels of proinflammatory cytokines [9], [11].

NOD mice spontaneously develop autoimmune diabetes (resembling type 1 diabetes in humans) and present a valuable tool to study the pathogenesis of infectious diseases in a diabetic host. We utilized a mouse model of bacterial peritonitis to measure recruitment of neutrophils to the site of an invasive S. aureus infection and to monitor the fate of those neutrophils after bacterial uptake. Although the immediate influx of neutrophils to the peritoneal cavity was similar for nondiabetic and diabetic mice, more neutrophils persisted at the infection site 48 h after challenge in diabetic mice compared to nondiabetic littermates. This is in contrast to our findings in a localized S. aureus infection of the mouse hindpaw in which diabetic mice showed a delayed inflammatory response in the infected tissue compared to that of age-matched nondiabetic littermates [17].

In a systemic infection ongoing neutrophil recruitment due to a higher bacterial burden in the peritoneal cavity of diabetic mice cannot be reliably distinguished from an increase in neutrophil half-life. To overcome this dilemma, we collected and evaluated neutrophils at a time point when cell counts were not significantly different between diabetic and nondiabetic animals (i.e., 18 h). A limitation of our approach, however, is that monitoring neutrophil apoptosis requires an ex vivo experimental design to preclude loss of apoptotic cells through clearance by macrophages in vivo. There are likely differences between the conditions of the ex vivo incubations in comparison to the conditions within the peritoneal cavity, and such differences could alter the rate of neutrophil apoptosis.

Neutrophils isolated from the infected peritoneal cavities of diabetic mice showed prolonged viability ex vivo in trypan blue exclusion assays compared to that of nondiabetic mice. Neutrophils are abundant but short lived cells, and constitutive apoptosis is essential for regulating neutrophil homeostasis [18]. Whereas constitutive apoptosis can be delayed through extracellular proinflammatory agents such as Toll-like receptor agonists [40], neutrophils undergo rapid apoptosis following phagocytosis of bacteria [19]. This pathogen-induced cell death is dependent on the production of neutrophil NADPH-oxidase derived reactive oxygen species (ROS) without the need for traditional death receptors [41]. ROS generated via the NADPH oxidase are essential for phosphatidylserine exposure during cell death induced by phorbol myristate acetate, but not for neutrophils undergoing spontaneous apoptosis [42]. Likewise, S. aureus induced neutrophil apoptosis is dose- and time-dependant, mediated by ROS and greatly increased in the presence of viable staphylococci [43], [44]. The fate of professional phagocytes is modulated depending on the nature of the bacterial pathogen and the host cell type involved. Whereas induction of apoptosis in longer lived professional phagocytes (such as macrophages) may present a way of undermining the host immune response, neutrophil apoptosis upon phagocytosis of bacteria seems to be essential for the resolution of infection [45].

S. aureus-infected diabetic mice showed a significantly lower rate of neutrophil apoptosis than infected nondiabetic littermates at several time points after isolation. Reduced apoptosis was not observed in neutrophils elicited by a sterile stimulus, but it was dependent on the presence of both bacteria and a functional NADPH oxidase, which is in line with studies by other authors reporting normal spontaneous apoptosis in neutrophils from diabetic patients [46]. As studies with S. aureus and neutrophils from mice with chronic granulomatous disease [21] or mice lacking beta-integrins [41] have shown, a NADPH-oxidase deficiency leads to reduced neutrophil apoptosis and elevated neutrophil numbers in inflammatory exudates, consistent with impaired recognition and clearance. However, our study demonstrates that a different disease entity (diabetes) leads to reduced neutrophil clearance resulting from a moderately reduced ROS production [17] instead of a complete absence of NADPH oxidase activity. Neutrophils from the blood of hyperglycemic NOD mice exhibit a diminished respiratory burst in response to S. aureus [17], and this may contribute to reduced pathogen-induced apoptosis in diabetic mice, resulting in higher neutrophil counts in peritoneal exudate fluids. Clinical studies have found a decreased rate of neutrophil apoptosis (eventually promoting tissue injury) in a patient group with major diabetic complications [47]. Previous studies have focused on the inability of diabetic patients to delay constitutive apoptosis of neutrophils upon stimulation with LPS [36], [48].

During the induction of apoptosis, neutrophils undergo significant alterations in gene expression profiles [22], including several genes encoding inflammatory cytokines. Consistent with reduced apoptosis, we showed that neutrophils from S. aureus infected diabetic mice failed to down regulate the production of TNFα over time. The failure to limit the production of mediators potentially causing tissue injury might contribute to the extensive tissue damage observed during infections in diabetic patients.

The clearance of neutrophils and their toxic contents, which could be deleterious for the surrounding tissue, is an important prerequisite for the resolution of infection. Neutrophil uptake by macrophages and their subsequent degradation is an important means of limiting tissue injury associated with inflammation [20]. Phosphatidylserine is externalized to the outer membrane layer during apoptosis and participates in neutrophil clearance by macrophages [49], a process that does not seem to be inhibited by high concentration of glucose [50]. Without apoptosis, neutrophil effector function is preserved and internalization by macrophages is prevented [51]. The ingestion of apoptotic neutrophils not only leads to the removal of cytotoxic content, but it also modulates the host immune response [52]. Previous studies have shown that after neutrophils engulf S. aureus, phosphatidylserine exposure occurs, resulting in neutrophil uptake by macrophages [21]. We compared these processes in diabetic and nondiabetic mice both ex vivo and in vivo. Under both conditions, we observed fewer S. aureus-stimulated neutrophils within macrophages from diabetic mice than nondiabetic mice. Macrophages from 5–6 wk old normoglycemic NOD mice showed reduced phagocytosis of apoptotic thymocytes when compared to macrophages from BALB/c mice [53]. However, our comparisons were made between infected age-matched diabetic and nondiabetic mice of the same genetic background, and thus the lower rate of neutrophil clearance by macrophages could be correlated with the diabetic state of the host. Gresham et al. showed that S. aureus may survive inside mouse neutrophils in vivo, and that infected neutrophils were sufficient to establish an infection when transferred to naïve animals [54]. Hence, diminished neutrophil apoptosis after uptake of S. aureus and subsequent impaired clearance by macrophages may contribute to the persistent nature of staphylococcal infections observed in diabetic patients. Our studies suggest that reduced neutrophil apoptosis contributes to the chronic inflammation, extensive tissue injury and persistent staphylococcal infections observed in diabetic hosts.


Drs. Rachel McLoughlin and Christopher Weidenmaier participated in useful discussions and provided helpful suggestions.


Competing Interests: The authors have declared that no competing interests exist.

Funding: FH was supported by grant BMBF-LPD 9901/8–157 from the German Academy of Sciences Leopoldina (http://www.leopoldina-halle.de/cms/en.html). JR was the recipient of a Juvenile Diabetes Research Foundation award (3-2004- 546; www.jdrf.org). JR and SP were supported by National Institutes of Health Infectious Disease Training Grant T32 AI07061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Adeghate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci. 2006;1084:1–29. [PubMed]
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–787. [PubMed]
3. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290:1884–1890. [PubMed]
4. Bader MS. Diabetic foot infection. Am Fam Physician. 2008;78:71–79. [PubMed]
5. Tuazon CU, Perez A, Kishaba T, Sheagren JN. Staphylococcus aureus among insulin-injecting diabetic patients. An increased carrier rate. JAMA. 1975;231:1272. [PubMed]
6. Boyko EJ, Lipsky BA, Sandoval R, Keane EM, Monahan JS, et al. NIDDM and prevalence of nasal Staphylococcus aureus colonization. San Luis Valley Diabetes Study. Diabetes Care. 1989;12:189–192. [PubMed]
7. Breen JD, Karchmer AW. Staphylococcus aureus infections in diabetic patients. Infect Dis Clin North Am. 1995;9:11–24. [PubMed]
8. Jacobsson G, Dashti S, Wahlberg T, Andersson R. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis. 2007;39:6–13. [PubMed]
9. Wetzler C, Kampfer H, Stallmeyer B, Pfeilschifter J, Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol. 2000;115:245–253. [PubMed]
10. Pierce GF. Inflammation in nonhealing diabetic wounds: the space-time continuum does matter. Am J Pathol. 2001;159:399–403. [PMC free article] [PubMed]
11. Graves DT, Naguib G, Lu H, Leone C, Hsue H, et al. Inflammation is more persistent in type 1 diabetic mice. J Dent Res. 2005;84:324–328. [PubMed]
12. Marhoffer W, Stein M, Schleinkofer L, Federlin K. Evidence of ex vivo and in vitro impaired neutrophil oxidative burst and phagocytic capacity in type 1 diabetes mellitus. Diabetes Res Clin Pract. 1993;19:183–188. [PubMed]
13. Nolan CM, Beaty HN, Bagdade JD. Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes. Diabetes. 1978;27:889–894. [PubMed]
14. Liberatore RR, Jr, Barbosa SF, Alkimin MG, Bellinati-Pires R, Florido MP, et al. Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2005;6:206–212. [PubMed]
15. Makino S, Hayashi Y, Muraoka Y, Tochino Y. Establishment of the nonobese-diabetic (NOD) mouse. In: Sakomoto N, Min HK, Baba S, editors. Current topics in clinicaland experimental aspects of diabetes mellitus. Amsterdam: Elsevier; 1985. pp. 25–32.
16. Leiter EH. The NOD mouse: a model for insulin-dependent diabetes mellitus. Curr Protoc Immunol Chapter. 2001;15:15–19. [PubMed]
17. Rich J, Lee JC. The pathogenesis of Staphylococcus aureus infection in the diabetic NOD mouse. Diabetes. 2005;54:2904–2910. [PubMed]
18. Filep JG, El Kebir D. Neutrophil apoptosis: a target for enhancing the resolution of inflammation. J Cell Biochem. 2009;108:1039–1046. [PubMed]
19. Luo HR, Loison F. Constitutive neutrophil apoptosis: mechanisms and regulation. Am J Hematol. 2008;83:288–295. [PubMed]
20. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, et al. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest. 1989;83:865–875. [PMC free article] [PubMed]
21. Hampton MB, Vissers MC, Keenan JI, Winterbourn CC. Oxidant-mediated phosphatidylserine exposure and macrophage uptake of activated neutrophils: possible impairment in chronic granulomatous disease. J Leukoc Biol. 2002;71:775–781. [PubMed]
22. Kobayashi SD, Voyich JM, Braughton KR, DeLeo FR. Down-regulation of proinflammatory capacity during apoptosis in human polymorphonuclear leukocytes. J Immunol. 2003;170:3357–3368. [PubMed]
23. McColl A, Bournazos S, Franz S, Perretti M, Morgan BP, et al. Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J Immunol. 2009;183:2167–2175. [PubMed]
24. Ludvigsson J. Why diabetes incidence increases–a unifying theory. Ann N Y Acad Sci. 2006;1079:374–382. [PubMed]
25. Eledrisi MS, Alshanti MS, Shah MF, Brolosy B, Jaha N. Overview of the diagnosis and management of diabetic ketoacidosis. Am J Med Sci. 2006;331:243–251. [PubMed]
26. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, et al. Infection and diabetes: the case for glucose control. Am J Med. 1982;72:439–450. [PubMed]
27. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341:1906–1912. [PubMed]
28. Tuazon CU. Skin and skin structure infections in the patient at risk: carrier state of Staphylococcus aureus. Am J Med. 1984;76:166–171. [PubMed]
29. Daeschlein G, Assadian O, Rangous I, Kramer A. Risk factors for Staphylococcus aureus nasal carriage in residents of three nursing homes in Germany. J Hosp Infect. 2006;63:216–220. [PubMed]
30. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, et al. Diagnosis and treatment of diabetic foot infections. Plast Reconstr Surg. 2006;117:212S–238S. [PubMed]
31. Akbar DH. Bacterial pneumonia: comparison between diabetics and non-diabetics. Acta Diabetol. 2001;38:77–82. [PubMed]
32. Khatib R, Johnson LB, Fakih MG, Riederer K, Khosrovaneh A, et al. Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome. Scand J Infect Dis. 2006;38:7–14. [PubMed]
33. Kourany WM, Miro JM, Moreno A, Corey GR, Pappas PA, et al. Influence of diabetes mellitus on the clinical manifestations and prognosis of infective endocarditis: a report from the International Collaboration on Endocarditis-Merged Database. Scand J Infect Dis. 2006;38:613–619. [PubMed]
34. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000–2006. J Infect Dis. 2008;198:336–343. [PubMed]
35. Alba-Loureiro TC, Hirabara SM, Mendonca JR, Curi R, Pithon-Curi TC. Diabetes causes marked changes in function and metabolism of rat neutrophils. J Endocrinol. 2006;188:295–303. [PubMed]
36. Glowacka E, Banasik M, Lewkowicz P, Tchorzewski H. The effect of LPS on neutrophils from patients with high risk of type 1 diabetes mellitus in relation to IL-8, IL-10 and IL-12 production and apoptosis in vitro. Scand J Immunol. 2002;55:210–217. [PubMed]
37. Repine JE, Clawson CC, Goetz FC. Bactericidal function of neutrophils from patients with acute bacterial infections and from diabetics. J Infect Dis. 1980;142:869–875. [PubMed]
38. Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care. 1992;15:256–260. [PubMed]
39. Balasoiu D, van Kessel KC, van Kats-Renaud HJ, Collet TJ, Hoepelman AI. Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care. 1997;20:392–395. [PubMed]
40. Francois S, El Benna J, Dang PM, Pedruzzi E, Gougerot-Pocidalo MA, et al. Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. J Immunol. 2005;174:3633–3642. [PubMed]
41. Zhang B, Hirahashi J, Cullere X, Mayadas TN. Elucidation of molecular events leading to neutrophil apoptosis following phagocytosis: cross-talk between caspase 8, reactive oxygen species, and MAPK/ERK activation. J Biol Chem. 2003;278:28443–28454. [PubMed]
42. Fadeel B, Ahlin A, Henter JI, Orrenius S, Hampton MB. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood. 1998;92:4808–4818. [PubMed]
43. Yamamoto A, Taniuchi S, Tsuji S, Hasui M, Kobayashi Y. Role of reactive oxygen species in neutrophil apoptosis following ingestion of heat-killed Staphylococcus aureus. Clin Exp Immunol. 2002;129:479–484. [PMC free article] [PubMed]
44. Lundqvist-Gustafsson H, Norrman S, Nilsson J, Wilsson A. Involvement of p38-mitogen-activated protein kinase in Staphylococcus aureus-induced neutrophil apoptosis. J Leukoc Biol. 2001;70:642–648. [PubMed]
45. DeLeo FR. Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis. 2004;9:399–413. [PubMed]
46. Tennenberg SD, Finkenauer R, Dwivedi A. Absence of lipopolysaccharide-induced inhibition of neutrophil apoptosis in patients with diabetes. Arch Surg. 1999;134:1229–1233; discussion 1233–1224. [PubMed]
47. Sudo C, Ogawara H, Saleh AW, Nishimoto N, Utsugi T, et al. Clinical significance of neutrophil apoptosis in peripheral blood of patients with type 2 diabetes mellitus. Lab Hematol. 2007;13:108–112. [PubMed]
48. Chanchamroen S, Kewcharoenwong C, Susaengrat W, Ato M, Lertmemongkolchai G. Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect Immun. 2009;77:456–463. [PMC free article] [PubMed]
49. Devitt A, Pierce S, Oldreive C, Shingler WH, Gregory CD. CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine. Cell Death Differ. 2003;10:371–382. [PubMed]
50. Savill JS, Henson PM, Haslett C. Phagocytosis of aged human neutrophils by macrophages is mediated by a novel “charge-sensitive” recognition mechanism. J Clin Invest. 1989;84:1518–1527. [PMC free article] [PubMed]
51. Koedel U, Frankenberg T, Kirschnek S, Obermaier B, Hacker H, et al. Apoptosis is essential for neutrophil functional shutdown and determines tissue damage in experimental pneumococcal meningitis. PLoS Pathog. 2009;5:e1000461. [PMC free article] [PubMed]
52. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol. 2002;2:965–975. [PubMed]
53. O'Brien BA, Huang Y, Geng X, Dutz JP, Finegood DT. Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes. 2002;51:2481–2488. [PubMed]
54. Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, et al. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol. 2000;164:3713–3722. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science
PubReader format: click here to try


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Gene
    Gene records that cite the current articles. Citations in Gene are added manually by NCBI or imported from outside public resources.
  • GEO Profiles
    GEO Profiles
    Gene Expression Omnibus (GEO) Profiles of molecular abundance data. The current articles are references on the Gene record associated with the GEO profile.
  • HomoloGene
    HomoloGene clusters of homologous genes and sequences that cite the current articles. These are references on the Gene and sequence records in the HomoloGene entry.
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
  • Taxonomy
    Taxonomy records associated with the current articles through taxonomic information on related molecular database records (Nucleotide, Protein, Gene, SNP, Structure).
  • Taxonomy Tree
    Taxonomy Tree

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...